实验方案(Protocols)

Recombinant Human CDCA3 Protein: Research Guide & Protocol

Recombinant Human CDCA3 Protein is a key research reagent enabling scientists to investigate the molecular mechanisms of cell cycle regulation, mitotic progression, and CDCA3-associated oncogenic pathways in vitro.

Product Name
Recombinant Human CDCA3 Protein
SKU
rp374385
Protein Function
CDCA3 (Cell Division Cycle Associated 3) is involved in cell cycle regulation and mitotic progression, functioning as part of the SCF ubiquitin ligase complex to promote mitotic entry.
Primary Applications
In vitro biochemical assays, protein–protein interaction studies, Western blot standard, cell cycle research, oncology target validation
Storage Recommendation
Store at -80°C upon receipt; avoid repeated freeze-thaw cycles to preserve protein activity.
Expression System
Recombinant protein expressed in a heterologous system (verify specific host system in product datasheet; flag for review).

Background: CDCA3 Biology and Research Relevance

CDCA3, also known as Cell Division Cycle Associated 3 (also referred to as Tome-1 in some literature), is a cell cycle regulatory protein that plays an important role in controlling the G2/M transition. It functions as an adaptor subunit within the SCF (Skp1–Cullin–F-box) E3 ubiquitin ligase complex, where it facilitates the ubiquitin-mediated degradation of key substrates such as Wee1 kinase, thereby promoting mitotic entry.

CDCA3 expression has been reported to be elevated in multiple cancer types, making it a subject of interest in oncology research and a potential biomarker or therapeutic target. Research scientists studying mitotic checkpoint mechanisms, cell proliferation, or cancer biology frequently require high-quality recombinant CDCA3 protein for in vitro biochemical experiments, structural studies, and assay development.

Recombinant Human CDCA3 Protein from Aladdin Scientific (SKU: rp374385) provides researchers with a reliable, ready-to-use reagent for these research applications.

Reconstitution and Handling Protocol

Proper handling of recombinant proteins is essential to maintain biological activity and ensure reproducible experimental results. Follow the steps below when working with Recombinant Human CDCA3 Protein:

  1. Centrifugation before opening: Briefly centrifuge the vial (e.g., 5–10 seconds at low speed) to collect any lyophilized or frozen material at the bottom before opening.
  2. Reconstitution: Reconstitute the protein in an appropriate buffer (typically sterile deionized water or PBS, pH 7.4, supplemented with a carrier protein such as 0.1% BSA if required for stability). Refer to the product-specific datasheet for the recommended reconstitution volume and buffer composition.
  3. Gentle mixing: Mix gently by pipetting or slow vortexing. Do not vigorously vortex, as this may denature the protein.
  4. Aliquoting: Prepare single-use aliquots immediately after reconstitution to avoid repeated freeze-thaw cycles, which can degrade protein integrity and activity.
  5. Storage after reconstitution: Store short-term aliquots at 4°C for up to 1 week, or at -20°C to -80°C for longer-term storage. Consult the datasheet for product-specific stability data.

Note: Specific reconstitution conditions (buffer, volume, additives) should always be confirmed in the product datasheet supplied with the reagent. The above represents general best-practice guidance for recombinant proteins.

Quality, Safety, and Regulatory Considerations

When working with Recombinant Human CDCA3 Protein, researchers should be aware of the following quality and safety considerations:

  • Purity and Quality: The recombinant protein is manufactured under controlled conditions. Review the Certificate of Analysis (CoA) provided with each lot for purity grade, endotoxin level, and activity data specific to that lot.
  • Endotoxin Content: If the protein is to be used in cell-based assays or in vivo studies, verify that endotoxin levels are within acceptable limits for the intended application. Consult the product datasheet or contact Aladdin Scientific technical support for lot-specific endotoxin data.
  • Biosafety: Recombinant Human CDCA3 Protein is derived from human gene sequences expressed in a recombinant host. Handle according to your institution's biosafety guidelines for recombinant proteins. Consult the Safety Data Sheet (SDS) provided by Aladdin Scientific before use.
  • Research Use Only: This product is intended for in vitro research use only. It is not approved for diagnostic, therapeutic, or veterinary applications.
  • Lot-to-Lot Consistency: For studies requiring strict reproducibility, purchase sufficient quantity from a single lot where possible. Contact Aladdin Scientific for lot reservation inquiries.

Frequently asked questions

What is CDCA3 and why is it important in cell cycle research?

CDCA3 (Cell Division Cycle Associated 3) is an adaptor protein within the SCF E3 ubiquitin ligase complex that promotes mitotic entry by facilitating ubiquitin-mediated degradation of Wee1 kinase. Its overexpression has been observed in several cancer types, making it a relevant target for oncology research and a protein of interest for understanding G2/M checkpoint regulation.

How should Recombinant Human CDCA3 Protein be stored to maintain activity?

Upon receipt, the protein should be stored at -80°C. Prepare single-use aliquots after reconstitution to avoid repeated freeze-thaw cycles, which can degrade protein integrity and reduce activity. Short-term storage at 4°C (up to approximately one week) is acceptable for aliquots in active use. Always consult the product-specific datasheet for confirmed stability data.

What applications is Recombinant Human CDCA3 Protein suitable for?

Recombinant Human CDCA3 Protein is suitable for in vitro biochemical assays such as ubiquitination assays, protein–protein interaction studies (co-immunoprecipitation, pull-down, surface plasmon resonance), Western blot as a positive control or molecular weight standard, ELISA antigen development, and cell-free functional assays. It is for research use only and not intended for clinical or diagnostic purposes.

How do I reconstitute Recombinant Human CDCA3 Protein?

Briefly centrifuge the vial before opening, then reconstitute in sterile deionized water or PBS (pH 7.4), optionally supplemented with 0.1% BSA as a carrier protein for added stability. Mix gently by pipetting; avoid vigorous vortexing. Always confirm the specific reconstitution volume and buffer from the product datasheet accompanying the reagent.

Is Recombinant Human CDCA3 Protein endotoxin-tested?

Endotoxin testing is typically performed during manufacturing; however, lot-specific endotoxin data should be confirmed by reviewing the Certificate of Analysis (CoA) provided with your shipment or by contacting Aladdin Scientific technical support. This is especially important if the protein will be used in cell-based assays or any application where endotoxin contamination could confound results.

References

  1. Ayad NG, Rankin S, Murakami M, Jebanathirajah J, Gygi S, Kirschner MW. Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC. Cell. 2003;113(1):101-113.
  2. Penas C, Ramachandran V, Bhaskara S, et al. Casein kinase 1delta-dependent Wee1 protein degradation. Journal of Biological Chemistry. 2014;289(27):18893-18903.
  3. Aladdin Scientific. Recombinant Human CDCA3 Protein, SKU rp374385. Product Datasheet. Aladdin Scientific.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

目录: 实验方案(Protocols)

Da — 若无特别说明,分子量单位默认为道尔顿。   Mw — 重均分子量。   Mn — 数均分子量。

产品仅供科研与开发使用,不用于人体、动物、诊断或治疗。

引用本文

阿拉丁科学.《Recombinant Human CDCA3 Protein: Research Guide & Protocol》. 阿拉丁知识库,更新于 2026年10月29日。 https://www.aladdin-e.com/zh_cn/faqs/recombinant-human-cdca3-protein-research-guide-protocol-en.html
这篇文章对您有帮助吗? Yes No 有 0 人觉得有帮助